1 |
Hisa T, Ohkubo H, Shiozawa S, et al. Growth process of small pancreatic carcinoma: A case report with imaging observation for 2 months. World-JGastroenterol,2008,14(12):1958-1960.
|
2 |
Rosenberg L,Lipsett M.Biotherape utic approaches to pancreatic cancer.Expert Opin Biol Ther,2003,3(2):319-337.
|
3 |
Gupta R,Dinda AK,Singh MK,et al.Macrocystic serous cystadenocarcinoma of the pancreas:the first report of a new pattern of pancreatic carcinoma.J Clin Pathol,2008,61(3):396-398.
|
4 |
Murakami Y,Uemura K,Sudo T,et al.Postoperative adjuvant chem otherapy improves survival after surgical resection for pancreatic carcinoma.J Gastrointest Surg,2008,12(3):534-541.
|
5 |
Hecht JR,Bedford R,Abbruzzese JL,et al.Aphase IP II Trial of Intra tumoral Endoscopic Ultra sound Injection of ONYX-015 with Intravenous Gemcitabine in Unresectable Pancreatic Carcinoma.Clin Cancer Res,2003,9(2):555-561.
|
6 |
Wesseling J G, Yamamoto M, Adachi Y, et al. Midkine and cyclo oxygen as epromoter sarepromising for adenoviralve ctorgenede livery of pancreatic carcinoma.Cancer Gene Ther,2001,8(12):990-996.
|
7 |
Fisher W E,Wu Y,Amaya F,et al.Somato statin receptor subtype gene therapy inhibits pancreatic cancer invitro.J Surg Res,2002,105(1):58-64.
|
8 |
Acobs A.Docetaxel plus gemcitabine or docetaxel plus cisplatin in ad vanced pancreatic carcinoma?.J Nat Clin Pract Oncol,2006,3(8):424-425.
|
9 |
Miki K, Xu M, Gupta A, et al. Methioninase cancer gene therapy with seleno methionineas suicide prodrug substrate.Cancer Research,2001, 61(18):6805-6810.
|
10 |
Calbo J,Marotta M,Cascallo M,et al.Adenovirus mediated wt-p16-re introduction in ducescell cycle arrest or apoptosis in pancreatic cancer.Cancer Gene Ther,2001,8(10):740-750.
|
11 |
Wang F, Sloss C, Zhang, X, et al. Membrane-bound heparin-binding epidermal growth factor like growth factor regulates E-cadherin expression in pancreatic carcinoma cells.Cancer-Research,2007,67(18):8486-8493.
|
12 |
Muscarella P, Knobloch TJ, Ulrich AB, et al. Identification and sequencing of the Syrian Golden hamster(Mesocricetusauratus) p16(INK4a) and p15(INK4b)cDNAs and their homozygous gene deletion in cheek pouch and pancreatic tumor cells.Gene,2001,278(122):235-243.
|
13 |
Sato T,Yamauchi N,Sasaki H,et al.An apoptosis inducing gene therapy for pancreatic cancer with acombination of 55 KDA tumor necrosis factor(TNF)receptor gene transfection and mutein TNF administration.Cancer Res,1998,58(8):1677-1683.
|
14 |
Zhu H,Liang ZY,Ren XY,et al. Small interfering RNAs targeting mutant K-ras inhibit human pancreatic carcinoma cells growth in vitro and in vivo.Cancer Biol Ther,2006,5(12):1693-1698.
|
15 |
Pantalone D,Pelo E,Minuti B,et al.P53 and DPC4 alterations in the bile of patients with pancreatic carcinoma.J Surg Oncol,2004,88(4):210-216.
|
16 |
Yu G,Zhu MH,Zhu Z,et al.Expression of ATM protein and its relationship with p53 in pancreatic carcinoma with tissue array.Pancreas,2004,28(4):421-426.
|
17 |
Adjei AA,Dy GK,Erlichman C,et al.Aphase Itrial of ISIS-2503,an antisense inhibitor of H-ras,incombination with gemcit abine inpatients with advanced cancer.Clin Cancer Research,2003,9(1):115-123.
|
18 |
Kubuschok B,Xie X,Jesnowski R.Expression of cancer testis antigens in pancreatic carcinoma cell lines,pancreatic adenocarcinoma and chronic pancreatitis.2004,109(4):568-575.
|
19 |
Detjen KM, Farwig K, Welzel M, et al. Interferon gamma inhibits growth of human pancreatic carcinoma cells via caspase-1 dependent induction of apoptosis.Gut,2001,49(2):251-262.
|
20 |
Hofsli E.The somato statin receptor family awindo wagainstnew diagnosis and therapy of cancer.Tidsskr Nor Laege foren,2002,122(5):487-491.
|
21 |
Gilliam AD,Watson SA.Emerging biologic alther apies for pancreatic carcinoma.Eur J Surg Oncol,2002,28(4):370-378.
|